26 December 2024
K&L Gates Advises Rocket Pharmaceuticals on Public Offering of Common Stock
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Whitney Smith Lead | K&L Gates | Partner | Not stated | New York |
| Sean Jones Lead | K&L Gates | Partner | Not stated | Charlotte |
| Mike Hinckle | K&L Gates | Partner | Not stated | Research Triangle Park |
| Kelly Terribile | K&L Gates | Partner | Not stated | Wilmington |
| Zidong Liu | K&L Gates | Associate | Not stated | New York |
| Jeff Pititto | K&L Gates | Associate | Not stated | Charlotte |
| Lindsey Taulbee | K&L Gates | Associate | Not stated | Charlotte |
| Tony Nolan | K&L Gates | Partner | Not stated | New York |
| Todd Gibson | K&L Gates | Partner | Not stated | Boston |
6 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 190m (US$189.8 million)
- What the figure measures
- Issue size
- Client
- Rocket Pharmaceuticals, Inc.Issuer
- Counterparties
- Morgan Stanley (Underwriters)
Leerink Partners (Underwriters)
Cantor (Underwriters)
LifeSci Capital (Underwriters)